‘Designer Drug’ Shows Early Neuroprotective Signal in Acute Ischemic Stroke – Medscape

  1. ‘Designer Drug’ Shows Early Neuroprotective Signal in Acute Ischemic Stroke  Medscape
  2. Silver Creek’s stroke hopeful yields mixed results in Phase II trial  Clinical Trials Arena
  3. Silver Creek Pharmaceuticals Receives FDA Fast Track Designation for Scp776 in Acute Ischemic Stroke  GlobeNewswire
  4. Silver Creek Pharmaceuticals Announces Positive Phase 2 Results for Scp776 in Acute Ischemic Stroke  Yahoo Finance

Continue Reading